Division of Neurology,
Department of Medicine,
Sunnybrook Health Sciences Centre,
Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre,
Division of Neurology, Department of Medicine
Mario Masellis has not added Biography.
If you are Mario Masellis and would like to personalize this page please email our Author Liaison for assistance.
Absence of linkage for schizophrenia on the short arm of chromosome 5 in multiplex Canadian families.
American journal of medical genetics Sep, 1997 | Pubmed ID: 9342193
Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder.
Behavioural brain research Mar, 2002 | Pubmed ID: 11864722
Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
The Journal of clinical psychiatry Mar, 2002 | Pubmed ID: 11926715
Pharmacogenomics in schizophrenia: the quest for individualized therapy.
Human molecular genetics Oct, 2002 | Pubmed ID: 12351588
Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity.
Canadian journal of psychiatry. Revue canadienne de psychiatrie Mar, 2003 | Pubmed ID: 12655903
Polymorphisms in glutamate decarboxylase genes: analysis in schizophrenia.
Psychiatric genetics Mar, 2004 | Pubmed ID: 15091314
The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective.
Biological psychiatry Nov, 2004 | Pubmed ID: 15522250
A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Nov, 2006 | Pubmed ID: 16760922
Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study.
Biological psychiatry Aug, 2007 | Pubmed ID: 17210141
Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.
Human genomics Dec, 2009 | Pubmed ID: 20038497
Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).
Journal of Alzheimer's disease : JAD , 2010 | Pubmed ID: 20930269
Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia.
Neuropsychiatric disease and treatment , 2011 | Pubmed ID: 21792308
Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.
Current pharmacogenomics and personalized medicine Sep, 2011 | Pubmed ID: 22279516
Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.
Current pharmacogenomics and personalized medicine Jun, 2011 | Pubmed ID: 22282718
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.
Current pharmacogenomics and personalized medicine Jan, 2012 | Pubmed ID: 22545073
Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study.
International journal of geriatric psychiatry Mar, 2013 | Pubmed ID: 22674572
Modulation of the default-mode network between rest and task in Alzheimer's Disease.
Cerebral cortex (New York, N.Y. : 1991) Jul, 2013 | Pubmed ID: 22693345
Investigation of C9orf72 in 4 Neurodegenerative Disorders.
Archives of neurology Sep, 2012 | Pubmed ID: 22964832
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
Alzheimer's research & therapy Jan, 2013 | Pubmed ID: 23302773
Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation.
Current pharmacogenomics and personalized medicine Mar, 2013 | Pubmed ID: 23531886
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
JAMA neurology Jun, 2013 | Pubmed ID: 23588557
Developing physician consensus on the reporting of patients with mild cognitive impairment and mild dementia to transportation authorities in a region with mandatory reporting legislation.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry Dec, 2014 | Pubmed ID: 24406250
Early-onset dementias: diagnostic and etiological considerations.
Alzheimer's research & therapy Jul, 2013 | Pubmed ID: 24565469
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.
Alzheimer's research & therapy Nov, 2013 | Pubmed ID: 24565514
Taking the Kidney Personally: The Quest for Novel Antigens of Idiopathic Membranous Nephropathy through Proteomic Approaches -?
Current pharmacogenomics and personalized medicine Mar, 2013 | Pubmed ID: 24795785
Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography.
Alzheimer's research & therapy , 2014 | Pubmed ID: 25484929
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.
The Lancet. Neurology Mar, 2015 | Pubmed ID: 25662776
White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study.
Alzheimer's & dementia : the journal of the Alzheimer's Association Feb, 2016 | Pubmed ID: 26208292
DRD2 and SLC6A3 moderate impact of maternal depressive symptoms on infant cortisol.
Psychoneuroendocrinology Dec, 2015 | Pubmed ID: 26342565
Physiological fluctuations in white matter are increased in Alzheimer's disease and correlate with neuroimaging and cognitive biomarkers.
Neurobiology of aging Jan, 2016 | Pubmed ID: 26476600
Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
Biochimica et biophysica acta May, 2016 | Pubmed ID: 26521151
Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.
Parkinsonism & related disorders Jan, 2016 | Pubmed ID: 26639982
Summary cortisol reactivity indicators: Interrelations and meaning.
Neurobiology of stress , 2015 | Pubmed ID: 26844238
MATERNAL SELF-REPORTED DEPRESSIVE SYMPTOMS AND MATERNAL CORTISOL LEVELS INTERACT TO PREDICT INFANT CORTISOL LEVELS.
Infant mental health journal Mar-Apr, 2016 | Pubmed ID: 26939829
Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.
PloS one , 2016 | Pubmed ID: 27100392
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.
Brain : a journal of neurology 07, 2016 | Pubmed ID: 27190009
Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.
The Lancet. Neurology Aug, 2016 | Pubmed ID: 27478953
'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?
Journal of neurology, neurosurgery, and psychiatry 12, 2016 | Pubmed ID: 27613160
Characterizing familial corticobasal syndrome due to Alzheimer's disease pathology and PSEN1 mutations.
Alzheimer's & dementia : the journal of the Alzheimer's Association May, 2017 | Pubmed ID: 27743520
Lack of Frank Agrammatism in the Nonfluent Agrammatic Variant of Primary Progressive Aphasia.
Dementia and geriatric cognitive disorders extra Sep-Dec, 2016 | Pubmed ID: 27790240
The spatial coefficient of variation in arterial spin labeling cerebral blood flow images.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism Sep, 2017 | Pubmed ID: 28058975
Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Jul, 2017 | Pubmed ID: 28137552
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.
Movement disorders : official journal of the Movement Disorder Society Feb, 2017 | Pubmed ID: 28150432
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.
Translational neurodegeneration , 2017 | Pubmed ID: 28360997
Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
Brain : a journal of neurology May, 2017 | Pubmed ID: 28369257
The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.
Movement disorders : official journal of the Movement Disorder Society 04, 2017 | Pubmed ID: 28370449
Development of cognitive screening test for the severely hearing impaired: Hearing-impaired MoCA.
The Laryngoscope May, 2017 | Pubmed ID: 28409842
Collagenosis of the Deep Medullary Veins: An Underrecognized Pathologic Correlate of White Matter Hyperintensities and Periventricular Infarction?
Journal of neuropathology and experimental neurology 04, 2017 | Pubmed ID: 28431180
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI).
Journal of magnetic resonance imaging : JMRI Jan, 2018 | Pubmed ID: 28480617
White matter hyperintensities are seen only inmutation carriers in the GENFI cohort.
NeuroImage. Clinical , 2017 | Pubmed ID: 28529873
Heritability of hippocampal subfield volumes using a twin and non-twin siblings design.
Human brain mapping Sep, 2017 | Pubmed ID: 28561418
Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28671116
Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI.
Journal of magnetic resonance imaging : JMRI Mar, 2018 | Pubmed ID: 28681479
Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease.
Neurobiology of aging Nov, 2017 | Pubmed ID: 28756941
Dopamine receptor D2 (DRD2), dopamine transporter solute carrier family C6, member 4 (SLC6A3), and catechol-O-methyltransferase (COMT) genes as moderators of the relation between maternal history of maltreatment and infant emotion regulation.
Development and psychopathology Aug, 2017 | Pubmed ID: 28803562
Maternal DRD2, SLC6A3, and OXTR genotypes as potential moderators of the relation between maternal history of care and maternal cortisol secretion in the context of mother-infant separation.
Biological psychology Oct, 2017 | Pubmed ID: 28890000
Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.
Annals of neurology Oct, 2017 | Pubmed ID: 28892572
Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.
Neurology Oct, 2017 | Pubmed ID: 28916533
Unraveling PINK1 regulation: Ubiquitination of its mature form and insights for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society Nov, 2017 | Pubmed ID: 28976028
Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28984590
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.
Neurobiology of aging Feb, 2018 | Pubmed ID: 29146050
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.
Neurobiology of aging Feb, 2018 | Pubmed ID: 29172163
The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration.
NPJ genomic medicine , 2016 | Pubmed ID: 29263818
Comment: Unraveling DNA sequence to identify cerebral indicators of dementia risk.
Neurology Jan, 2018 | Pubmed ID: 29282334
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.
Journal of neurology, neurosurgery, and psychiatry Feb, 2018 | Pubmed ID: 29434051
Allison A. Dilliott1,2,
Sali M.K. Farhan3,
Mahdi Ghani4,
Christine Sato4,
Eric Liang5,
Ming Zhang4,
Adam D. McIntyre1,
Henian Cao1,
Lemuel Racacho6,7,
John F. Robinson1,
Michael J. Strong1,8,
Mario Masellis9,10,
Dennis E. Bulman6,7,
Ekaterina Rogaeva4,
Anthony Lang10,11,
Carmela Tartaglia4,10,
Elizabeth Finger12,13,
Lorne Zinman9,
John Turnbull14,
Morris Freedman10,15,
Rick Swartz9,
Sandra E. Black9,16,
Robert A. Hegele1,2
1Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University,
2Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University,
3Analytic and Translational Genetics Unit, Center for Genomic Medicine, Harvard Medical School, Massachusetts General Hospital, Stanley Centre for Psychiatric Research, Broad Institute of MIT and Harvard,
4Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto,
5School of Medicine, Faculty of Health Sciences, Queen's University,
6Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, University of Ottawa,
7CHEO Research Institute, Faculty of Medicine, University of Ottawa,
8Department of Clinical Neurological Sciences, Western University,
9Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto,
10Division of Neurology, Department of Medicine, University of Toronto,
11Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital,
12Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University,
13Parkwood Institute, St. Joseph's Health Care,
14Department of Medicine, Division of Neurology, McMaster University,
15Division of Neurology, Department of Medicine, Baycrest Health Sciences,
16Canadian Partnership for Stroke Recovery Sunnybrook Site, Sunnybrook Health Science Centre, University of Toronto
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados